ARGX
argenx raises $1.0 billion in gross proceeds in a global offering
Tuesday, February 2, 2021 BiopharmaWatch Research 1 min read Key Takeaway: argenx raises $1.0 billion in gross proceeds in a global offering
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+36%
120-day peak, hindsight
Typical move
4.7%
average across 12 past catalysts
Lead asset
Empasiprubart
Phase 2 · AChR-Ab Seropositive Generalized Myasthenia Gravis
Full Press Release Details
argenx raises $1.0 billion in gross proceeds in a global offering.